Sebia

Sebia is a global leader in specialty diagnostics and offers advanced tools for protein analysis and the monitoring of chronic diseases such as cancer, diabetes, and autoimmune disorders, developing precise and reliable technologies that empower laboratories and clinicians to improve global health outcomes.
Sebia GmbH, part of the French group founded in 1967, embodies this spirit by working hand in hand with public and private laboratories. By providing equipment that transforms complex biological processes into meaningful clinical insights, Sebia enables more targeted therapies and enhances people’s well-being.